MYDX - MyDx, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
+0.0001 (+50.00%)
At close: 3:44PM EDT
Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
  • Short Term
    2W - 6W
  • Mid Term
    6W - 9M
  • Long Term
Previous Close0.0001
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0001 - 0.0002
52 Week Range0.0000 - 0.0009
Avg. Volume6,754,074
Market Cap885,189
Beta (5Y Monthly)-5.88
PE Ratio (TTM)N/A
EPS (TTM)-0.0010
Earnings DateApr 25, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • GlobeNewswire

    MyDx Announces Plans to Focus on OrganaDx in a Letter to Shareholders

    It has been a story of excitement for a vision, coupled with the hope of seeing come to life a revolutionary product that could one day help all of us Trust and Verify® what we put into our minds and bodies.  This hope was partially realized with the creation of CannaDx™, a portable analyzer currently being used by thousands of consumers in the Cannabis industry to test the chemical profile of their cannabis and tracking how it makes them feel. From a business perspective, we expect the CannaDx product business unit, as a standalone division of the company, will continue to market, sell, and service this product, and believe it should be able to self-sustain itself and operate as a profitable business in the coming years.

  • GlobeNewswire

    MyDx Announces Letter to Shareholders

    SAN DIEGO, Aug. 07, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- MyDx, Inc. (OTC: MYDX), a leader in science based cannabis health technologies, today issued a press release with the following letter to shareholders. Any statements in this press release that are not statements of historical fact may be considered to be forward-looking statements.